Redmile Group’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-265,736
| Closed | -$33.3M | – | 101 |
|
|
2020
Q4 | $33.3M | Sell |
265,736
-12,200
| -4% | -$1.53M | 0.4% | 54 |
|
|
2020
Q3 | $28.2M | Sell |
277,936
-1,400
| -0.5% | -$142K | 0.52% | 50 |
|
|
2020
Q2 | $27.2M | Sell |
279,336
-163,364
| -37% | -$15.9M | 0.5% | 51 |
|
|
2020
Q1 | $36.8M | Sell |
442,700
-7,100
| -2% | -$590K | 1.03% | 31 |
|
|
2019
Q4 | $50M | Buy |
449,800
+54,400
| +14% | +$6.05M | 1.2% | 26 |
|
|
2019
Q3 | $39.2M | Buy |
+395,400
| New | +$39.2M | 1.31% | 24 |
|
|
2019
Q2 | – | Sell |
-174,000
| Closed | -$19.2M | – | 96 |
|
|
2019
Q1 | $19.2M | Sell |
174,000
-20,800
| -11% | -$2.29M | 0.56% | 47 |
|
|
2018
Q4 | $17.9M | Sell |
194,800
-5,200
| -3% | -$478K | 0.72% | 43 |
|
|
2018
Q3 | $22M | Buy |
+200,000
| New | +$22M | 0.68% | 51 |
|
|
2018
Q2 | – | Sell |
-245,314
| Closed | -$20.4M | – | 89 |
|
|
2018
Q1 | $20.4M | Sell |
245,314
-5,300
| -2% | -$440K | 0.79% | 38 |
|
|
2017
Q4 | $22.8M | Sell |
250,614
-151,400
| -38% | -$13.8M | 0.99% | 37 |
|
|
2017
Q3 | $30.6M | Buy |
+402,014
| New | +$30.6M | 1.51% | 24 |
|